Codexis Inc, headquartered in the USA, specializes in the development of biocatalyst products and enzyme optimization services. Utilizing its proprietary CodeEvolver technology, Codexis caters to ...
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Codexis. The company’s shares closed yesterday at $2.42. Take advantage of TipRanks Premium at 50% off! Unlock ...
Codexis will announce Q1 2025 financial results on May 14, 2025, with a conference call at 4:30 PM ET. Codexis, Inc. announced that it will release its financial results for the first quarter of ...
Codexis, Inc. (Nasdaq: CDXS) today unveiled results from the pilot-scale demonstration of the company’s carbon capture technology conducted at the Nat ...
Core enzymes for ECO Synthesis™ technology have transitioned from research into development and scale-up as the first step in securing the raw materials supply chain REDWOOD CITY, Calif., March ...
Total revenues were $15.3 million for the second quarter of 2025 compared to $8.0 million in the second quarter of 2024. The increase was primarily due to variability in customers’ manufacturing ...
Codexis, Inc. (Nasdaq: CDXS) and seqWell, Inc. today announced the initiation of a strategic partnership and investment to accelerate the commercializ ...
After releasing the pricing details of a just-announced common stock offering, shares of Codexis (NASDAQ: CDXS), a company focused on protein engineering, fell as much as 13% in early morning ...
Our AI model demonstrates 52% historical accuracy for CDXS predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
VAR_0__株価予測に影響を与える要因は何か?
当社の分析では、CODEXIS, INC.の財務指標、Industrial Applications and Servicesセクターの動向、市場センチメント、テクニカル指標、業績データ、株価に影響を与えるマクロ経済要因を考慮しています。